Advanced Heart Failure and Transplant Cardiology · Miami, FL
NPI
1043301997
Since 2006
Specialty
Advanced Heart Failure and Transplant Cardiology
Code 207RA0001X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
7400 SW 87th Ave Ste 100
Miami, FL, 33173
Phone (786) 204-4201
Groups this clinician bills Medicare through
Medicare paid, 2024
$52K
641 services
Medicare patients, 2024
118
Average age 75
Drug cost, 2024
$10.7M
2,589 prescriptions
Company payments, 2025
$10K
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sandra V Chaparro was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 149 times for 74 patients. In total Sandra V Chaparro billed 641 services in 24 codes, and Medicare paid $52K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-31.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 149 | 74 | $14.68 | $2,187 |
| 99214 Office E&M - Established | Office | 107 | 54 | $106.08 | $11K |
| 99232 Hospital E&M - Subsequent | Facility | 102 | 28 | $71.49 | $7,291 |
| 99233 Hospital E&M - Subsequent | Facility | 75 | 21 | $107.70 | $8,077 |
| 99215 Office E&M - Established | Office | 43 | 31 | $152.77 | $6,569 |
| 99222 Hospital E&M - Initial | Facility | 27 | 27 | $116.63 | $3,149 |
| 99223 Hospital E&M - Initial | Facility | 19 | 19 | $156.89 | $2,981 |
| 93000 Electrocardiogram | Office | 17 | 13 | $12.34 | $210 |
| 99204 Office E&M - New | Office | 16 | 16 | $153.19 | $2,451 |
| 93451 Percutaneous Transcatheterization | Facility | 13 | 13 | $103.24 | $1,342 |
By year: 2022 $74K for 653 services; 2023 $63K for 638 services; 2024 $52K for 641 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sandra V Chaparro prescribed most often to Medicare patients was Entresto (Sacubitril/Valsartan), with 291 prescriptions and refills. In total Sandra V Chaparro wrote 2,589 Medicare prescriptions that cost $10.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Entresto Sacubitril/Valsartan | 291 | 619 | 100 | $339K |
| Spironolactone Generic | 267 | 679 | 95 | $1,746 |
| Vyndamax Tafamidis | 244 | 290 | 31 | $6.4M |
| Jardiance Empagliflozin | 187 | 361 | 51 | $201K |
| Metoprolol Succinate Generic | 159 | 442 | 67 | $2,616 |
| Farxiga Dapagliflozin Propanediol | 146 | 301 | 51 | $166K |
| Atorvastatin Calcium Generic | 94 | 270 | 40 | $1,080 |
| Digoxin Generic | 82 | 212 | 36 | $3,854 |
| Opsumit Macitentan | 81 | 89 | Under 11 | $1.2M |
| Eliquis Apixaban | 76 | 147 | 26 | $85K |
| Bumetanide Generic | 69 | 152 | 23 | $1,660 |
| Sildenafil Citrate Generic | 65 | 119 | 17 | $46K |
| Tadalafil Generic | 52 | 86 | 14 | $51K |
| Furosemide Generic | 47 | 125 | 24 | $628 |
| Bisoprolol Fumarate Generic | 47 | 132 | 20 | $1,121 |
Brand drugs: 1,358 claims; generic drugs: 1,231 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sandra V Chaparro $10K ($10K in general payments such as food, travel and fees) from 12 companies. The largest payer was Alnylam Pharmaceuticals Inc. with $8,588.
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. ALNY | 13 | $8,588 |
| Abbott Laboratories ABT | 7 | $611 |
| Medtronic, Inc. MDT | 2 | $265 |
| Actelion Pharmaceuticals US, Inc. JNJ | 2 | $208 |
| Abiomed JNJ | 2 | $180 |
| Edwards Lifesciences Corporation EW | 1 | $153 |
| Boston Scientific Corporation BSX | 1 | $151 |
| Novo Nordisk Inc NVO | 2 | $143 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $44.22 |
| Endotronix, Inc. | 1 | $20 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.